QCLS insider transaction filings
Q/C TECHNOLOGIES, INC. — 20 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-05-14. Screen QCLS transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-14 | 4 | Voss Chelsea Sierra — Director | Purchase (P): 1,753 @ $3.15 | EDGAR |
| 2026-04-15 | 4 | White Billy Joe — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-04-15 | 4 | Voss Chelsea Sierra — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-04-15 | 4 | Silverman Joshua — Executive Chairman, Director | Grant/award (A): 162,162 @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-04-15 | 4 | Glass Mitchell — Chief Medical Officer, Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-04-15 | 4 | Friscia Stephen — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-04-15 | 4 | Bernstein Bruce — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-01-30 | 4 | Voss Chelsea Sierra — Director | Grant/award (A): 212,500 @ $0 · Grant/award (A): 25,000 @ $0 · Grant/award (A): 212,500 (derivative) @ $0 | EDGAR |
| 2025-11-18 | 4 | PharmaCyte Biotech, Inc. — 10% owner | Purchase (P): 889,865 (derivative) · Purchase (P): 889,865 (derivative) | EDGAR |
| 2025-11-17 | 4 | Glass Mitchell — Director, Chief Medical Off., Director | Grant/award (A): 11,420 @ $0 | EDGAR |
| 2025-11-17 | 4 | White Billy Joe — Director | Grant/award (A): 22,839 @ $0 | EDGAR |
| 2025-11-14 | 4 | Silverman Joshua — Executive Chairman, Director | Grant/award (A): 91,356 @ $0 | EDGAR |
| 2025-11-14 | 4 | Friscia Stephen — Director | Grant/award (A): 22,839 @ $0 | EDGAR |
| 2025-11-14 | 4 | Bernstein Bruce — Director | Grant/award (A): 25,000 @ $0 | EDGAR |
| 2025-11-14 | 4 | RAUCH GARY M | Grant/award (A): 11,420 @ $0 | EDGAR |
| 2025-10-06 | 4 | White Billy Joe — Director | Grant/award (A): 2,161 @ $0 | EDGAR |
| 2025-10-06 | 4 | Silverman Joshua — Executive Chairman, Director | Grant/award (A): 8,644 @ $0 | EDGAR |
| 2025-10-06 | 4 | RAUCH GARY M | Grant/award (A): 1,080 @ $0 | EDGAR |
| 2025-10-06 | 4 | Glass Mitchell — Director, Chief Medical Off., Director | Grant/award (A): 1,080 @ $0 | EDGAR |
| 2025-10-06 | 4 | Friscia Stephen — Director | Grant/award (A): 2,161 @ $0 | EDGAR |
Recent 8-K events — Q/C TECHNOLOGIES, INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-02 | 8-K | 1.02 — Termination of a Material Definitive Agreement 8.01 — Other Events | EDGAR |
| 2026-03-13 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-23 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-09 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-14 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-06 | 8-K/A | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-10-03 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 3.03 — Material Modification to Rights of Security Holders 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-26 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-10 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-05 | 8-K/A | 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=QCLS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →